Clinical Trial Update: A Phase III Study of FE 999913 in Japanese Female Patients Undergoing Fertility Treatment [Phase 3]

View source ↗

Summary

Phase III trial evaluating FE 999913 for luteal hormone supplementation in Japanese women undergoing fertility treatment; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• FE 999913

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Luteal Hormone Supplementation | Phase 3 | Status: COMPLETED | Results posted: 2014-08-19